| Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study AE Grulich, R Guy, J Amin, F Jin, C Selvey, J Holden, HMA Schmidt, ... The lancet HIV 5 (11), e629-e637, 2018 | 333 | 2018 |
| Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ... The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018 | 308 | 2018 |
| Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting P Read, R Lothian, K Chronister, R Gilliver, J Kearley, GJ Dore, ... International Journal of Drug Policy 47, 209-215, 2017 | 172 | 2017 |
| Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods J Tapsall, P Read, C Carmody, C Bourne, S Ray, A Limnios, T Sloots, ... Journal of medical microbiology 58 (5), 683-687, 2009 | 170 | 2009 |
| Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence DJ Templeton, P Read, R Varma, C Bourne Sexual health 11 (3), 217-229, 2014 | 120 | 2014 |
| When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery? PJ Read, S Mandalia, P Khan, U Harrisson, C Naftalin, Y Gilleece, ... Aids 26 (9), 1095-1103, 2012 | 99 | 2012 |
| We know DAA s work, so now what? Simplifying models of care to enhance the hepatitis C cascade JV Lazarus, JM Pericàs, C Picchio, J Cernosa, M Hoekstra, N Luhmann, ... Journal of internal medicine 286 (5), 503-525, 2019 | 94 | 2019 |
| Increasing trends of syphilis among men who have sex with men in high income countries P Read, CK Fairley, EPF Chow Sexual health 12 (2), 155-163, 2015 | 94 | 2015 |
| Long-term survival in HIV positive patients with up to 15 years of antiretroviral therapy H McManus, CC O'Connor, M Boyd, J Broom, D Russell, K Watson, ... PloS one 7 (11), e48839, 2012 | 94 | 2012 |
| Clinical aspects of adult syphilis PJ Read, B Donovan Internal medicine journal 42 (6), 614-620, 2012 | 85 | 2012 |
| Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: the SIMPLIFY study EB Cunningham, J Amin, JJ Feld, J Bruneau, O Dalgard, J Powis, ... International journal of drug policy 62, 14-23, 2018 | 83 | 2018 |
| Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis EPF Chow, D Callander, CK Fairley, L Zhang, B Donovan, R Guy, ... Clinical Infectious Diseases 65 (3), 389-395, 2017 | 80 | 2017 |
| Raltegravir‐emtricitabine‐tenofovir as HIV nonoccupational post‐exposure prophylaxis in men who have sex with men: safety, tolerability and adherence J McAllister, P Read, A McNulty, WWY Tong, A Ingersoll, A Carr HIV medicine 15 (1), 13-22, 2014 | 76 | 2014 |
| Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study AD Marshall, M Micallef, A Erratt, J Telenta, C Treloar, H Everingham, ... International Journal of Drug Policy 26 (10), 984-991, 2015 | 72 | 2015 |
| Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective … AE Grulich, F Jin, BR Bavinton, B Yeung, MA Hammoud, J Amin, ... The Lancet HIV 8 (8), e486-e494, 2021 | 69 | 2021 |
| Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study H Valerio, M Alavi, D Silk, C Treloar, M Martinello, A Milat, A Dunlop, ... Clinical infectious diseases 73 (1), e69-e78, 2021 | 69 | 2021 |
| Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: a systematic review … J Grebely, L Tran, L Degenhardt, A Dowell-Day, T Santo Jr, S Larney, ... Clinical Infectious Diseases 73 (1), e107-e118, 2021 | 67 | 2021 |
| One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia PJ Read, EA Limnios, A McNulty, D Whiley, MM Lahra Sexual health 10 (5), 460-462, 2013 | 67 | 2013 |
| Moving towards hepatitis C microelimination among people living with human immunodeficiency virus in Australia: the CEASE study M Martinello, J Yee, SR Bartlett, P Read, D Baker, JJ Post, R Finlayson, ... Clinical Infectious Diseases 71 (6), 1502-1510, 2020 | 66 | 2020 |
| Adherence to once-daily and twice-daily direct-acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy EB Cunningham, B Hajarizadeh, J Amin, AH Litwin, E Gane, C Cooper, ... Clinical infectious diseases 71 (7), e115-e124, 2020 | 63 | 2020 |
